DOT SOLUTIONS

Employees with undiagnosed or untreated sleep apnea are 5x more likely to be involved in an at-fault accident and open your organization for litigation risk.
READ THE REPORT

FATIGUE MANAGEMENT SOLUTIONS FOR THE TRANSPORTATION INDUSTRY

We offer a full suite of fatigue management solutions for the transportation industry that gets drivers tested for obstructive sleep apnea (OSA), diagnosed and on treatment in a matter of days.
1

RISK SCREENING

Our data-driven, clinically-proven risk assessment evaluates individual risk factors for OSA with a high level of confidence.

2

HOME SLEEP APNEA TESTING

Our home sleep apnea testing program leverages state-of-the-art equipment to evaluate patients for OSA. Drivers are offered a one-on-one appointment with a physician that is board certified in Sleep Medicine. Testing equipment can be mailed directly to the patient or dispensed from a medical clinical or operations center.

3

TREATMENT OPTIONS

Once a driver tests positive for OSA, they receive an individualized treatment plan. While CPAP is the gold standard treatment option for drivers with moderate-to-severe OSA, some drivers may opt for other treatment options including hypoglossal nerve stimulation, oral appliance therapy, or a positional therapy device.

4

CPAP ACCLIMATION & COMPLIANCE MONITORING

Diagnostic testing and treatment for OSA is half the battle. Our compliance solution ensures that drivers achieve and maintain compliance in accordance with Department of Transportation (DOT) standards. This program includes custom reporting and risk escalation for non-compliant drivers. Our compliance program mitigates your legal risk, improves safety margins & crash rates, and saves huge healthcare dollars.

We Take Pride In Our Numbers.

50+
Years of combined clinical experience.
25+
Strategic partners.
5000+
Patients being monitored.
93%
Average compliance with treated patients.
$450+
Saved on average per member, per month.

SCHNEIDER NATIONAL NUMBERS

44%

Improvement in fatigue-related accidents.

30%

Increase in retention among treated drivers.

2800+

Patients being monitored.